MASS
908 DEVICES INC.NasdaqResearch view
Healthcare · Laboratory Analytical Instruments · Small-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$412.1M
Enterprise Value$356.5M
Income$19.5M
Sales$56.2M
Book/sh$3.48
Cash/sh$1.71
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio3.86
Current Ratio4.24
Debt/Eq0.10
EPS (ttm)$0.54
EPS this Y125.5%
EPS past 3/5Y—
Sales past 3/5Y6.2%
EPS Y/Y TTM125.5%
Sales Y/Y TTM17.7%
Shs Outstand41.33M
ROA10.3%
ROE13.6%
ROIC-44.7%
Gross Margin50.6%
Oper. Margin-70.1%
Profit Margin34.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$42.2M
2021
$46.9M
2022
$50.2M
2023
$47.7M
2024
$56.2M
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $42.2M | $46.9M | $50.2M | $47.7M | $56.2M |
| Gross Profit | $23.2M | $26.0M | $25.3M | $24.5M | $28.4M |
| Operating Income | $-22.1M | $-35.4M | $-42.8M | $-57.4M | $-39.4M |
| Net Income | $-22.2M | $-33.6M | $-36.4M | $-72.2M | $19.5M |
| Diluted EPS | $-0.79 | $-1.07 | $-1.13 | $-2.12 | $0.54 |
| Operating Cash Flow | $-29.1M | $-20.9M | $-25.1M | $-30.2M | $-23.7M |
| Free Cash Flow | $-29.8M | $-23.0M | $-27.1M | $-30.8M | $-24.6M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Cash-flow detail unavailable in this filing.
—
COMMUNITY · $MASS0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Measuring & Controlling Devices, Nec
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.